Implican B.V.

Industry
Medical Device Manufacturing
Founded Year
2016
Headquarters
Groningen, Netherlands
Employee Count
15

Key People

Assessment

Team
Aspect: First-time 10+ yrs
Summary: Experienced leadership with over a decade in MedTech.

The leadership team at Implican B.V. comprises individuals with over ten years of experience in the medical technology sector, providing a solid foundation for the company's strategic direction and product development.

Clinical Need
Aspect: Very Strong
Summary: High demand for solutions to reduce anastomotic leakage.

Anastomotic leakage is a significant complication in colorectal surgeries, leading to increased morbidity and mortality. Implican's focus on innovative surgical devices aims to mitigate this issue, addressing a pressing clinical need.

Competition
Aspect: Somewhat crowded
Summary: Several players in the anastomotic device market.

The anastomotic device market includes established companies like Medtronic and Ethicon, presenting a competitive landscape for new entrants like Implican.

Technical Challenge
Aspect: Moderate
Summary: Developing effective devices to prevent leakage.

Creating devices that effectively prevent anastomotic leakage involves moderate technical challenges, including ensuring biocompatibility, ease of use, and consistent performance in varied surgical scenarios.

Patent
Aspect: Strong
Summary: Patented technology for surgical devices.

Implican's patented technology offers protection against competitors and can serve as a valuable asset in partnerships or licensing agreements.

Financing
Aspect: SBIR/SEED
Summary: Secured 1 million in seed funding.

The 1 million seed funding from NextGen Ventures and NOM enables Implican to advance its device development and initiate preclinical and clinical testing, marking a positive step in its financial trajectory.

Regulatory
Aspect: Concept Stage
Summary: Early development; regulatory approval pending.

As Implican is in the early stages of development, it has yet to undergo clinical trials and obtain necessary regulatory approvals, which are critical milestones for market entry.

Opportunity Rollup

Odds of Success
3.7
Peak Market Share
5.5
Segment CAGR
6.6%
Market Segment
Anastomotic Leak Devices
Market Sub Segment
Colorectal Surgery Devices
Year Post Launch Market Penetration (%)
1 0.28
2 0.82
3 1.93
4 3.85
5 5.50

Key Takeaway

Implican B.V. addresses a critical need in colorectal surgery with innovative technology, backed by experienced leadership and initial funding, yet faces challenges in a competitive market and regulatory approvals.